Skip to main content
. 2023 Jul 5;7(21):6790–6799. doi: 10.1182/bloodadvances.2023009961

Table 2.

Proportions and timing of CAR-T–associated neurotoxicity

Neurotoxicity, CTCAE version 5.0 Patients who were evaluable (n = 20)
Rating by CAR-T day 30
 Any grade, n (%) 10 (50)
 Grade ≥3, n (%) 5 (25)
Median event duration, d (range)
 Any grade 24 (8-39)
 Grade ≥3 7 (2-28)

CTCAE, Common Terminology Criteria for Adverse Events.

Value is unadjusted for stage 1 analysis.

Event duration was calculated from the onset of the first CAR-T neurotoxicity event to the end date of the last CAR-T neurotoxicity event.